52 related articles for article (PubMed ID: 18268120)
1. Pancreatic cancer and factors associated with the insulin resistance syndrome in the Korean cancer prevention study.
Berrington de Gonzalez A; Yun JE; Lee SY; Klein AP; Jee SH
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):359-64. PubMed ID: 18268120
[TBL] [Abstract][Full Text] [Related]
2. Association between hepatitis B or hepatitis C virus infection and risk of pancreatic cancer: a systematic review and meta-analysis of cohort studies.
Zhao JF; Teng QP; Lv Y; Li XY; Ding Y
Ther Adv Infect Dis; 2023; 10():20499361231212161. PubMed ID: 37954404
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus infection: An insight into the clinical connection and molecular interaction between hepatitis B virus and host extrahepatic cancer risk.
Min Y; Wei X; Xia X; Wei Z; Li R; Jin J; Liu Z; Hu X; Peng X
Front Immunol; 2023; 14():1141956. PubMed ID: 36936956
[TBL] [Abstract][Full Text] [Related]
4. Temporal Association of Total Serum Cholesterol and Pancreatic Cancer Incidence.
Wang QL; Khil J; Hong S; Lee DH; Ha KH; Keum N; Kim HC; Giovannucci EL
Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432624
[TBL] [Abstract][Full Text] [Related]
5. Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal adenocarcinoma (PDAC): a nested case-control study.
Tan PS; Garriga C; Clift A; Liao W; Patone M; Coupland C; Bashford-Rogers R; Sivakumar S; Hippisley-Cox J
Gut; 2023 Mar; 72(3):512-521. PubMed ID: 35760494
[TBL] [Abstract][Full Text] [Related]
6. The Role of Circulating Protein and Metabolite Biomarkers in the Development of Pancreatic Ductal Adenocarcinoma (PDAC): A Systematic Review and Meta-analysis.
Kumar S; Santos RJ; McGuigan AJ; Singh U; Johnson P; Kunzmann AT; Turkington RC
Cancer Epidemiol Biomarkers Prev; 2022 May; 31(5):1090-1102. PubMed ID: 34810209
[TBL] [Abstract][Full Text] [Related]
7. Association between blood pressure and risk of cancer development: a systematic review and meta-analysis of observational studies.
Seretis A; Cividini S; Markozannes G; Tseretopoulou X; Lopez DS; Ntzani EE; Tsilidis KK
Sci Rep; 2019 Jun; 9(1):8565. PubMed ID: 31189941
[TBL] [Abstract][Full Text] [Related]
8. Chronic hepatitis B infection and non-hepatocellular cancers: A hospital registry-based, case-control study.
An J; Kim JW; Shim JH; Han S; Yu CS; Choe J; Lee D; Kim KM; Lim YS; Chung YH; Lee YS; Suh DJ; Kim JH; Lee HC
PLoS One; 2018; 13(3):e0193232. PubMed ID: 29543815
[TBL] [Abstract][Full Text] [Related]
9. Recognition criteria for occupational cancers in relation to hepatitis B virus and hepatitis C virus in Korea.
Kim H; Chung YK; Kim I
Ann Occup Environ Med; 2018; 30():6. PubMed ID: 29423229
[TBL] [Abstract][Full Text] [Related]
10. Young adulthood and adulthood adiposity in relation to incidence of pancreatic cancer: a prospective study of 0.5 million Chinese adults and a meta-analysis.
Pang Y; Holmes MV; Kartsonaki C; Guo Y; Yang L; Bian Z; Chen Y; Bragg F; Iona A; Millwood IY; Chen J; Li L; Chen Z
J Epidemiol Community Health; 2017 Nov; 71(11):1059-1067. PubMed ID: 28900029
[TBL] [Abstract][Full Text] [Related]
11. Serum glucose and risk of cancer: a meta-analysis.
Crawley DJ; Holmberg L; Melvin JC; Loda M; Chowdhury S; Rudman SM; Van Hemelrijck M
BMC Cancer; 2014 Dec; 14():985. PubMed ID: 25526881
[TBL] [Abstract][Full Text] [Related]
12. Diabetes type II, other medical conditions and pancreatic cancer risk: a prospective study in The Netherlands.
Eijgenraam P; Heinen MM; Verhage BA; Keulemans YC; Schouten LJ; van den Brandt PA
Br J Cancer; 2013 Nov; 109(11):2924-32. PubMed ID: 24149173
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B or C viral infection and risk of pancreatic cancer: a meta-analysis of observational studies.
Xu JH; Fu JJ; Wang XL; Zhu JY; Ye XH; Chen SD
World J Gastroenterol; 2013 Jul; 19(26):4234-41. PubMed ID: 23864789
[TBL] [Abstract][Full Text] [Related]
14. Risk of pancreatic cancer in relation to ABO blood group and hepatitis C virus infection in Korea: a case-control study.
Woo SM; Joo J; Lee WJ; Park SJ; Han SS; Kim TH; Koh YH; Kim HB; Hong EK
J Korean Med Sci; 2013 Feb; 28(2):247-51. PubMed ID: 23400555
[TBL] [Abstract][Full Text] [Related]
15. Total serum cholesterol and cancer incidence in the Metabolic syndrome and Cancer Project (Me-Can).
Strohmaier S; Edlinger M; Manjer J; Stocks T; Bjørge T; Borena W; Häggström C; Engeland A; Nagel G; Almquist M; Selmer R; Tretli S; Concin H; Hallmans G; Jonsson H; Stattin P; Ulmer H
PLoS One; 2013; 8(1):e54242. PubMed ID: 23372693
[TBL] [Abstract][Full Text] [Related]
16. Cancer risk in type 2 diabetes mellitus: metabolic links and therapeutic considerations.
Sun G; Kashyap SR
J Nutr Metab; 2011; 2011():708183. PubMed ID: 21773024
[TBL] [Abstract][Full Text] [Related]
17. Total cholesterol and cancer risk in a large prospective study in Korea.
Kitahara CM; Berrington de González A; Freedman ND; Huxley R; Mok Y; Jee SH; Samet JM
J Clin Oncol; 2011 Apr; 29(12):1592-8. PubMed ID: 21422422
[TBL] [Abstract][Full Text] [Related]
18. Predictors of fasting serum insulin and glucose and the risk of pancreatic cancer in smokers.
Meinhold CL; Berrington de Gonzalez A; Albanes D; Weinstein SJ; Taylor PR; Virtamo J; Stolzenberg-Solomon RZ
Cancer Causes Control; 2009 Jul; 20(5):681-90. PubMed ID: 19083105
[TBL] [Abstract][Full Text] [Related]
19. Association between hepatitis B virus and pancreatic cancer.
Hassan MM; Li D; El-Deeb AS; Wolff RA; Bondy ML; Davila M; Abbruzzese JL
J Clin Oncol; 2008 Oct; 26(28):4557-62. PubMed ID: 18824707
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]